|
Effects of Surgical Approach on Burkitt’s Lymphoma Therapy |
03/04/2025 - 4:00pm to 5:00pm CST |
|
Pediatric Essential Thrombocytosis Indications for Intervention |
03/18/2025 - 4:00pm to 5:00pm CDT |
|
Monoclonal Gammopathy of Undetermined Significance (MGUS) and Post-Transplant Lymphoproliferative Disorder (PTLD): Insights and Clinical Implications |
03/25/2025 - 4:00pm to 5:00pm CDT |
|
Pediatric Chronic Myeloid Leukemia (CML): Diagnosis, Management, and Outcomes |
04/01/2025 - 4:00pm to 5:00pm CDT |
|
Treatment of Pediatric Ph-like ALL: Lessons from a High-Risk Case of EBF1::PDGFRB Fusion |
04/15/2025 - 4:00pm to 5:00pm CDT |
|
Sequelae of Parvovirus in the Sickle Cell Disease Population |
04/22/2025 - 4:00pm to 5:00pm CDT |
|
Anemia and Thrombocytopenia: TTP or HUS? |
05/13/2025 - 4:00pm to 5:00pm CDT |
|
Post Cancer Treatment Vaccine Guidance |
05/27/2025 - 4:00pm to 5:00pm CDT |
|
HEADSS UP: Reproductive Health in Sickle Cell Patients |
06/03/2025 - 4:00pm to 5:00pm CDT |
|
Arguing with a Fallacy Navigating Parental Refusal of Pediatric Acute Lymphoblastic Leukemia Treatment |
06/10/2025 - 4:00pm to 5:00pm CDT |